Minimally Invasive Medical Sciences Limited (the “Company” or “Minimally Invasive”) and its subsidiaries (collectively, the “Group”) is a leading medical device group focused on innovating, manufacturing and selling high-end medical devices on a global scale. With a diverse product portfolio currently used in more than 20,000 hospitals around the world, the Group operates several business divisions around the world, including cardiovascular intervention business, orthopedic medical device business, heart rhythm management (“heart rhythm management”) business, aortic and peripheral vascular intervention business, neurological intervention business, structural heart disease business, surgical robot business, etc. In the Minimally Invasive Family, employees at home and abroad from more than 30 countries work together to provide patients around the world with inclusive, true, and beautiful solutions that can prolong and reshape lives, thus helping hundreds of millions of people on Earth successfully cross the 115-year-old lifeline. The Group is people-oriented. We firmly believe that everyone has equal medical treatment rights, the right to health, and the right to live longer, and hope to cooperate with all sectors of society to actively create various transformative medical methods for everyone to enjoy this right. Through the practical application of innovative science, we continuously develop leading technology and products and services to provide patients with inclusive, true, and beautiful solutions that can prolong and reshape lives. Around the world, on average, every 5 seconds, a minimally invasive product is used to save and prolong lives or improve the quality of life. We have a large and continuously rich intellectual property library and a strong research and development (“R&D”) team. We work closely with internationally renowned doctors and scientists around the world to develop a range of products that meet the highest quality and highest clinical standards. We are committed to providing first-class medical technology, producing next-generation medical devices and providing treatment solutions for chronic diseases. Our R&D team applies expertise to ensure continuous innovation in the latest products. With global R&D, production, marketing and service networks located in Shanghai, Suzhou, Jiaxing, and Shenzhen, China; Irvine, Memphis, Boston, France; near Milan, Italy; Aachen, England; Santo Domingo, Dominica; Mumbai, India; and San Jose, Costa Rica; and strong emphasis on technological innovation (it has obtained more than 10,000 patents (including applications)), Minimalist Innovation is committed to achieving its corporate vision. Our products affect the lives of many people every day, and we strive for excellence and live up to their expectations. We are proud that minimally invasive products consistently meet the highest quality standards and ensure improved patient health. We know that our products bring hope and faith to many people around the world, so each and every one of our employees takes personal responsibility to achieve our vision. Our commercial achievements allow us to give back to society, and our commitment to social responsibility is also an important aspect of our culture and philosophy. Minimally Invasive Group is committed to mitigating and even eliminating serious threats to life safety from various chronic diseases, and is playing an increasingly important and even indispensable role in the process of continuously improving the average healthy life expectancy of humans, making an important contribution to satisfying humanity's never-ending pursuit of “healthy longevity.” vision People-oriented Build a human-centered, emerging high-tech medical supercluster. mission Continuous innovation Provide inclusive truth and beauty solutions that prolong and reshape lives. Note: These figures include those of the Group's associated companies.